Synchrony Medical, a respiratory care technology company and creator of the FDA-cleared LibAirty airway clearance system, announced it has secured additional funding through a $1M investment from the New Jersey Innovation Evergreen Fund. Matching an Edge Medical Ventures investment, the funding will be used to accelerate U.S. commercial operations, support continued clinical research and product development, and expand patient access to LibAirty through respiratory clinics, hospitals, and homecare networks nationwide.